glp 1 receptor agonists mechanism of action GLP-1 – Peripheral Brain Frontiers | GLP-1 receptor agonist

Description

Nat Rev Endocrinol 2020

[DOI] [PMC free article] [PubMed] [Google Scholar] 90.Neeland I.J., Linge J., Birkenfeld A.L

In conclusion, accumulating studies indicate that DPP4 inhibitors are clinically useful for patients with T2DM accompanied by liver dysfunction based on fatty liver, and that DPP4 inhibition affects liver function regardless of diabetic status and obesity

Although prospective studies specifically targeting PCOS + MASLD with pregnancy outcomes as the primary endpoint are currently lacking, a robust inference can be drawn based on the pathophysiological framework of MASLD and evidence from the general population: proactively identifying and reducing MASLD and ectopic fat load prior to pregnancy may be a key step in improving both periconception outcomes and long-term prognosis (68, 76)

However, genome editing-induced Exe4 secretion in the liver led to sustained plasma Exe4 levels, highlighting its potential for long-term clinical benefits, such as improved treatment adherence and prevention of relapse